Product
UMC119-06-05
2 clinical trials
3 indications
Indication
FrailtyIndication
OsteoarthritisIndication
KneeClinical trial
A Phase 1, Open Label, Dose Escalation Study to Evaluate the Safety and Tolerability After Intra Articular (IA) Injection of UMC119-06-05 in Adult Subjects With Mild to Moderate Knee Osteoarthritis(KOA).Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
A Phase I, Open Label, Dose Escalation Study to Evaluate the Safety and Tolerability After Intravenous Infusion of UMC119-06-05 in Elderly Subjects With Mild to Moderate Frailty Syndrome.Status: Recruiting, Estimated PCD: 2024-12-01